Stephanie Mehlis to Humans
This is a "connection" page, showing publications Stephanie Mehlis has written about Humans.
Connection Strength
0.092
-
Patient and physician perspectives on disease burden in chronic spontaneous urticaria: A real-world US survey. Ann Allergy Asthma Immunol. 2025 Mar; 134(3):315-323.e3.
Score: 0.029
-
Biologics for the primary care physician: Review and treatment of psoriasis. Dis Mon. 2019 Mar; 65(3):51-90.
Score: 0.019
-
Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study. J Eur Acad Dermatol Venereol. 2025 Jun; 39(6):1152-1162.
Score: 0.007
-
From laboratory to clinic: rationale for biologic therapy. Dermatol Clin. 2004 Oct; 22(4):371-7, vii-viii.
Score: 0.007
-
Updates in atopic dermatitis for the primary care physician: A review of advances in the understanding and treatment of atopic dermatitis. Dis Mon. 2024 Apr; 70(4):101687.
Score: 0.007
-
The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol. 2003 Aug; 49(2 Suppl):S44-50.
Score: 0.007
-
Do regional geography and race influence management of chronic spontaneous urticaria? J Allergy Clin Immunol. 2022 12; 150(6):1260-1264.e7.
Score: 0.006
-
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1693-1699.
Score: 0.004
-
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol. 2011 Sep; 165(3):652-60.
Score: 0.003
-
Pruritic, papular eruption, and concomitant neurologic symptoms: Churg-Strauss syndrome presenting with mononeuritis multiplex. Skinmed. 2010 Mar-Apr; 8(2):111-2.
Score: 0.003